Protecting the malaria drug arsenal: halting the rise and spread of amodiaquine resistance by monitoring the PfCRT SVMNT type - PubMed (original) (raw)

Protecting the malaria drug arsenal: halting the rise and spread of amodiaquine resistance by monitoring the PfCRT SVMNT type

Juliana M Sa et al. Malar J. 2010.

Abstract

The loss of chloroquine due to selection and spread of drug resistant Plasmodium falciparum parasites has greatly impacted malaria control, especially in highly endemic areas of Africa. Since chloroquine removal a decade ago, the guidelines to treat falciparum malaria suggest combination therapies, preferentially with an artemisinin derivative. One of the recommended partner drugs is amodiaquine, a pro-drug that relies on its active metabolite monodesethylamodiaquine, and is still effective in areas of Africa, but not in regions of South America. Genetic studies on P. falciparum parasites have shown that different pfcrt mutant haplotypes are linked to distinct levels of chloroquine and amodiaquine responses. The pfcrt haplotype SVMNT (termed after the amino acids from codon positions 72-76) is stably present in several areas where amodiaquine was introduced and widely used. Parasites with this haplotype are highly resistant to monodesethylamodiaquine and also resistant to chloroquine. The presence of this haplotype in Africa was found for the first time in 2004 in Tanzania and a role for amodiaquine in the selection of this haplotype was suggested. This commentary discusses the finding of a second site in Africa with high incidence of this haplotype. The >50% SVMNT haplotype prevalence in Angola represents a threat to the rise and spread of amodiaquine resistance. It is paramount to monitor pfcrt haplotypes in every country currently using amodiaquine and to re-evaluate current combination therapies in areas where SVMNT type parasites are prevalent.

PubMed Disclaimer

Figures

Figure 1

Current worldwide distribution of PfCRT types (codons 72-76, based on the report of more than a single parasite isolate). Regions with previous history of AQ use coincide with areas where the SVMNT haplotype is prevalent. Figure adapted and updated from Sa et al [3].

Cited by

Efficacy of artemisinin-based combination treatments of uncomplicated falciparum malaria in under-five-year-old Nigerian children.
Oguche S, Okafor HU, Watila I, Meremikwu M, Agomo P, Ogala W, Agomo C, Ntadom G, Banjo O, Okuboyejo T, Ogunrinde G, Odey F, Aina O, Sofola T, Sowunmi A. Oguche S, et al. Am J Trop Med Hyg. 2014 Nov;91(5):925-935. doi: 10.4269/ajtmh.13-0248. Epub 2014 Sep 22. Am J Trop Med Hyg. 2014. PMID: 25246693 Free PMC article. Clinical Trial.
Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.
Mekonnen SK, Aseffa A, Berhe N, Teklehaymanot T, Clouse RM, Gebru T, Medhin G, Velavan TP. Mekonnen SK, et al. Malar J. 2014 Jun 25;13:244. doi: 10.1186/1475-2875-13-244. Malar J. 2014. PMID: 24964730 Free PMC article.
Plasmodium falciparum drug resistance in Angola.
Fançony C, Brito M, Gil JP. Fançony C, et al. Malar J. 2016 Feb 9;15:74. doi: 10.1186/s12936-016-1122-z. Malar J. 2016. PMID: 26858018 Free PMC article. Review.
Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.
Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL. Zhou RM, et al. Malar J. 2016 May 10;15(1):265. doi: 10.1186/s12936-016-1306-6. Malar J. 2016. PMID: 27160572 Free PMC article.
Surveillance of Plasmodium falciparum pfcrt haplotypes in southwestern uganda by high-resolution melt analysis.
Kassaza K, Long AC, McDaniels JM, Andre M, Fredrickson W, Nyehangane D, Orikiriza P, Operario DJ, Bazira J, Mwanga-Amumpaire JA, Moore CC, Guler JL, Boum Y 2nd. Kassaza K, et al. Malar J. 2021 Feb 25;20(1):114. doi: 10.1186/s12936-021-03657-7. Malar J. 2021. PMID: 33632242 Free PMC article.

References

1. Gama BE, Pereira de Carvalho GA, Lutucuta Kosi FJ, Almeida de Oliveira NK, Fortes F, Rosenthal PJ, Daniel Ribeiro CT, Ferreira da Cruz MD. Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene. Malar J. 2010;9:174. doi: 10.1186/1475-2875-9-174. - DOI - PMC - PubMed
1. Alifrangis M, Dalgaard MB, Lusingu JP, Vestergaard LS, Staalsoe T, Jensen AT, Enevold A, Ronn AM, Khalil IF, Warhurst DC, Lemnge MM, Theander TG, Bygbjerg IC. Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania. J Infect Dis. 2006;193:1738–1741. doi: 10.1086/504269. - DOI - PubMed
1. Sa JM, Twu O, Hayton K, Reyes S, Fay MP, Ringwald P, Wellems TE. Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Proc Natl Acad Sci USA. 2009;106:18883–18889. doi: 10.1073/pnas.0911317106. - DOI - PMC - PubMed
1. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naude B, Deitsch KW, Su XZ, Wootton JC, Roepe PD, Wellems TE. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell. 2000;6:861–871. doi: 10.1016/S1097-2765(05)00077-8. - DOI - PMC - PubMed
1. Menegon M, Pearce RJ, Inojosa WO, Pisani V, Abel PM, Matondo A, Bisoffi Z, Majori G, Ord R, Warhurst DC, Roper C, Severini C. Monitoring for multidrug-resistant Plasmodium falciparum isolates and analysis of pyrimethamine resistance evolution in Uige province, Angola. Trop Med Int Health. 2009;14:1251–1257. doi: 10.1111/j.1365-3156.2009.02369.x. - DOI - PubMed

Protecting the malaria drug arsenal: halting the rise and spread of amodiaquine resistance by monitoring the PfCRT SVMNT type - PubMed (original) (raw)